drugset / Trial / NCT01052025

Curcumin Therapy in Patients With Impaired Glucose Tolerance and Insulin Resistance

NCT01052025 ↗

RandomizedParallel-groupSingle-blindPrevention

Summary

The incidence rate of type 2 diabetes in Thai populations is high and increasing every year. Cardiovascular disease is the main complication of this disease, which has been defined as an important cause of death among Diabetic patients. This disease is now becoming a major health problem and causes a great economic loss to the country. Evidence shows that Curcumin, Thai herbal medicine, has the effectiveness of prevention and delay of type 2 diabetes. However, there is no scientific study that aims to prove the efficacy of this herb particularly for prevention and delay the disease in Patients with impaired glucose tolerance (pre-diabetes) and insulin resistance.

Timeline

Start
2009-08
Primary completion
2010-03
Completion
2010-04

Outcome

Met primary endpoint

paper After 9 months of treatment, 16.4% of subjects in the placebo group were diagnosed with T2DM, whereas none were diagnosed with T2DM in the curcumin-treated group. PMID 22773702 ↗

paper A 9-month curcumin intervention in a prediabetic population significantly lowered the number of prediabetic individuals who eventually developed T2DM. PMID 22773702 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Curcumin Small molecule 750 mg —